By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim efficacy data from the Phase I stage of its ...